We will use clinical examinations, MRI brain imaging and genetics to try to predict how severe your MS will be.
We want to remove the uncertainty that a diagnosis of MS can bring.
Scotland has one of the highest rates of multiple sclerosis (MS) in the world. An estimated 10,000 people in this country have this disabling condition.
When people are newly diagnosed with MS, they do not know what the future will hold. Most people experience occasional bouts of symptoms called 'relapses', but doctors cannot predict how often, and how severe, these relapses will be. This can make it difficult for people to make decisions about their lifestyle, work and family.
People with MS need a tool to predict - as early as possible - how severe their MS is likely to be.
There are 11 licensed drugs to reduce the relapse rate in MS. Choosing the right one for the right person at the right time can be challenging. Doctors need a tool to help them make an informed choice.
Doctors and scientists at the University of Edinburgh Anne Rowling Regenerative Neurology Clinic, with Stratified Medicine Scotland, are leading the FutureMS research study to try to predict disease severity in people with MS. We aim to help doctors prescribe the right medication at the right time for the right person. This is sometimes called ‘personalised medicine’.
We are recruiting people recently diagnosed with relapsing-onset MS who might like to take part in FutureMS. If you agree to participate, we will use clinical examinations, MRI brain imaging and genetics to try to predict the severity of your MS.
FutureMS might help doctors decide the most appropriate treatment for people with MS. It might help to remove the uncertainty that a diagnosis of MS can bring.
Would you consider taking part in this important research project?
Am I eligible?
(1) You must be at least 18 years of age, living in Scotland, and have been diagnosed with relapsing-onset MS within the last six months.
(2) You must not be on any disease-modifying therapy, or taking part in any other clinical trial.
(3) You must be able to travel to Aberdeen, Dundee, Edinburgh, Glasgow or Inverness for two visits 12 months apart (reasonable travel costs will be reimbursed).
(4) You must be willing to undergo two clinical examinations, two MRI brain scans, and give a blood sample.
Download more information
Meet The Team
Margaret Ann McLeod
Javier Carod Artal
FutureMS is actively recruiting participants.
If you are considering registering, please complete the form below, and we will get in touch with you.
For all other enquiries, email us at firstname.lastname@example.org
Data Protection Act
All information is held by the University and will be treated confidentially and with sensitivity. Your details will be used for the purposes of the FutureMS project only. Under the terms of the 1998 Data Protection Act you have the right to object to the use of your details for any purpose at any time. If you wish to change your details or how we contact you, or wish to request a copy of the information we hold about you, please email email@example.com, call us on (0131) 465-9517 or write to us at University of Edinburgh, Anne Rowling Regenerative Neurology Clinic, Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB.